Funder: Alzheimer's Association
Due Dates: May 28, 2026 (Letter of Intent) | August 14, 2026 (Full application)
Funding Amounts: Up to $750,000 total for up to 2 years; nonprofits may request up to 10% indirect costs, none for for-profits.
Summary: Supports translational research advancing therapies for tauopathies, focusing on moving promising candidates toward clinical development for diseases like Alzheimer's, PSP, and FTD.
Key Information: Letter of Intent required; only invited applicants may submit full proposals.